| Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program) S Beurtheret, P Mordant, X Paoletti, E Marijon, DS Celermajer, P Léger, ... European heart journal 34 (2), 112-120, 2013 | 278 | 2013 |
| Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study G Lebreton, M Schmidt, M Ponnaiah, T Folliguet, M Para, J Guihaire, ... The Lancet Respiratory Medicine 9 (8), 851-862, 2021 | 170 | 2021 |
| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 143 | 2020 |
| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 143 | 2020 |
| Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation P Mordant, D Nakajima, R Kalaf, I Iskender, L Maahs, P Behrens, ... The Journal of Heart and Lung Transplantation 35 (10), 1245-1254, 2016 | 107 | 2016 |
| Are RAS mutations predictive markers of resistance to standard chemotherapy? Y Loriot, P Mordant, E Deutsch, KA Olaussen, JC Soria Nature reviews Clinical oncology 6 (9), 528, 2009 | 104 | 2009 |
| FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro A Joannes, S Brayer, V Besnard, J Marchal-Sommé, M Jaillet, P Mordant, ... American Journal of Physiology-Lung Cellular and Molecular Physiology …, 2016 | 103 | 2016 |
| Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France M Lafarge, P Mordant, G Thabut, L Brouchet, PE Falcoz, A Haloun, ... The Journal of Heart and Lung Transplantation 32 (9), 905-913, 2013 | 102 | 2013 |
| Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis P Augustin, M Desmard, P Mordant, S Lasocki, JM Maury, N Heming, ... Critical Care 15 (2), 1-8, 2011 | 101 | 2011 |
| Nutritional status and postoperative outcome after pneumonectomy for lung cancer P Bagan, P Berna, F De Dominicis, JCDN Pereira, P Mordant, ... The Annals of thoracic surgery 95 (2), 392-396, 2013 | 98 | 2013 |
| Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer? P Mordant, A Arame, F De Dominicis, C Pricopi, C Foucault, A Dujon, ... European Journal of Cardio-Thoracic Surgery 41 (3), 617-622, 2012 | 97 | 2012 |
| Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal M Riquet, C Rivera, C Pricopi, A Arame, P Mordant, C Foucault, A Dujon, ... European Journal of Cardio-Thoracic Surgery 47 (3), 543-549, 2014 | 96 | 2014 |
| Sleeve lobectomy may provide better outcomes than pneumonectomy for non-small cell lung cancer. A decade in a nationwide study PB Pagès, P Mordant, S Renaud, L Brouchet, PA Thomas, M Dahan, ... The Journal of Thoracic and Cardiovascular Surgery, 2016 | 93 | 2016 |
| Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells P Mordant, Y Loriot, B Lahon, Y Castier, G Lesèche, JC Soria, ... PloS one 6 (10), e26073, 2011 | 73 | 2011 |
| Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation D Nakajima, Y Watanabe, A Ohsumi, M Pipkin, M Chen, P Mordant, ... The Journal of Heart and Lung Transplantation 38 (11), 1214-1223, 2019 | 72 | 2019 |
| Surgery for metastatic pleural extension of non-small-cell lung cancer P Mordant, A Arame, C Foucault, A Dujon, FLP Barthes, M Riquet European Journal of Cardio-Thoracic Surgery 40 (6), 1444-1449, 2011 | 65 | 2011 |
| Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor M Riquet, A Legras, P Mordant, C Rivera, A Arame, L Gibault, C Foucault, ... The Annals of thoracic surgery 98 (1), 224-231, 2014 | 64 | 2014 |
| Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread A Legras, P Mordant, A Arame, C Foucault, A Dujon, FLP Barthes, ... The Annals of thoracic surgery 97 (4), 1156-1162, 2014 | 62 | 2014 |
| Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications P Mordant, B Grand, A Cazes, C Foucault, A Dujon, FLP Barthes, ... The Annals of thoracic surgery 95 (4), 1189-1195, 2013 | 60 | 2013 |
| Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination P Mordant, Y Loriot, C Leteur, J Calderaro, J Bourhis, M Wislez, JC Soria, ... Molecular cancer therapeutics 9 (2), 358-368, 2010 | 59 | 2010 |
